Rhenman & Partners Asset Management AB Diversified Active

CIK: 0001599882 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 13, 2015

Total Value ($000): $593,072 (100.0% shares, 0.0% debt)

Holdings (89)

SELECT SECTOR SPDR TR 5.4%
Value ($000) $31,900 Shares 440,000 Est. Cost Unrealized
Alexion Pharmaceuticals Inc 3.4%
Value ($000) $19,926 Shares 114,978 Est. Cost $161.94 Unrealized
Celgene Corp 2.9%
Value ($000) $17,407 Shares 151,000 Est. Cost $113.27 Unrealized
MRK Merck & Co Inc 2.9%
Value ($000) $17,244 Shares 300,000 Est. Cost $38.32 Unrealized +5.2%
BIIB Biogen Inc 2.9%
Value ($000) $17,185 Shares 40,700 Est. Cost $335.29 Unrealized +17.6%
AMGN Amgen Inc 2.7%
Value ($000) $15,825 Shares 99,000 Est. Cost $108.83 Unrealized +5.7%
ALKS Alkermes Plc 2.7%
Value ($000) $15,730 Shares 258,000 Est. Cost $53.58 Unrealized +27.5%
GILD Gilead Sciences Inc 2.6%
Value ($000) $15,603 Shares 159,000 Est. Cost $64.85 Unrealized +8.8%
UNH United Health Group Inc 2.6%
Value ($000) $15,378 Shares 130,000 Est. Cost $81.05 Unrealized +15.0%
CVS CVS Health Corp 2.5%
Value ($000) $14,965 Shares 145,000 Est. Cost $60.39 Unrealized +23.0%
Actavis Plc 2.3%
Value ($000) $13,482 Shares 45,300 Est. Cost $258.48 Unrealized
ABBV AbbVie Inc 2.2%
Value ($000) $12,879 Shares 220,000 Est. Cost $37.18 Unrealized +4.5%
CAH Cardinal Health Inc 2.2%
Value ($000) $12,764 Shares 141,400 Est. Cost $57.37 Unrealized +10.9%
ESPR Esperion Therapeutics Inc 2.0%
Value ($000) $11,753 Shares 126,926 Est. Cost $22.47 Unrealized +187.2%
Rite Aid Corp 1.9%
Value ($000) $11,092 Shares 1,276,462 Est. Cost $6.53 Unrealized
INCY Incyte Corp Ltd 1.9%
Value ($000) $10,999 Shares 120,000 Est. Cost $69.98 Unrealized +18.1%
Nektar Therapeutics 1.8%
Value ($000) $10,963 Shares 996,600 Est. Cost $11.22 Unrealized
UHS Universal Health Services Inc B 1.7%
Value ($000) $10,241 Shares 87,000 Est. Cost $105.74 Unrealized 0.0%
REGN Regeneron Pharmaceuticals Inc 1.7%
Value ($000) $9,933 Shares 22,000 Est. Cost $334.35 Unrealized +26.1%
JAZZ Jazz Pharmaceuticals Plc 1.6%
Value ($000) $9,503 Shares 55,000 Est. Cost $167.61 Unrealized +2.4%
LLY Eli Lilly & Co 1.6%
Value ($000) $9,372 Shares 129,000 Est. Cost $53.64 Unrealized +9.3%
BMRN BioMarin Pharmaceutical Inc 1.6%
Value ($000) $9,347 Shares 75,000 Est. Cost $76.23 Unrealized +39.0%
Medivation Inc 1.5%
Value ($000) $8,906 Shares 69,000 Est. Cost $80.67 Unrealized
Anthem Inc 1.5%
Value ($000) $8,801 Shares 57,000 Est. Cost $154.40 Unrealized
MCK McKesson Corp 1.4%
Value ($000) $8,596 Shares 38,000 Est. Cost $181.90 Unrealized +12.3%
BMY Bristol Myers Squibb Co 1.4%
Value ($000) $8,321 Shares 129,000 Est. Cost $35.96 Unrealized +20.8%
Receptos Inc 1.2%
Value ($000) $7,173 Shares 43,500 Est. Cost $122.51 Unrealized
Valeant Pharm Intl Inc 1.2%
Value ($000) $7,150 Shares 36,000 Est. Cost $198.61 Unrealized
Cyberonics Inc 1.2%
Value ($000) $7,011 Shares 108,000 Est. Cost $64.95 Unrealized
VRTX Vertex Pharmaceuticals Inc 1.2%
Value ($000) $6,842 Shares 58,000 Est. Cost $87.26 Unrealized +37.3%
Becton Dickinson & Co 1.1%
Value ($000) $6,746 Shares 46,982 Est. Cost $143.59 Unrealized
Orexigen Therapeutics Inc 1.1%
Value ($000) $6,513 Shares 831,800 Est. Cost $6.65 Unrealized
Isis Pharmaceuticals Inc 1.1%
Value ($000) $6,494 Shares 102,000 Est. Cost $52.32 Unrealized
Intercept Pharmaceuticals Inc 1.1%
Value ($000) $6,486 Shares 23,000 Est. Cost $226.71 Unrealized
Cempra Inc 1.1%
Value ($000) $6,358 Shares 185,300 Est. Cost $34.31 Unrealized
CYH Community Health Syst Inc 1.0%
Value ($000) $6,169 Shares 118,000 Est. Cost $37.22 Unrealized +11.2%
ACAD Acadia Pharmaceuticals Inc 0.9%
Value ($000) $5,573 Shares 171,000 Est. Cost $24.02 Unrealized +43.1%
HCA HCA Holdings Inc 0.9%
Value ($000) $5,567 Shares 74,000 Est. Cost $53.97 Unrealized +23.7%
ALNY Alnylam Pharmaceuticals Inc 0.9%
Value ($000) $5,534 Shares 53,000 Est. Cost $90.65 Unrealized +11.8%
SUPN Supernus Pharmaceuticals Inc 0.9%
Value ($000) $5,450 Shares 450,800 Est. Cost $8.32 Unrealized +13.5%
Medtronic Plc 0.9%
Value ($000) $5,381 Shares 69,000 Est. Cost $64.46 Unrealized
Laboratory Corp of America Hgs 0.8%
Value ($000) $4,918 Shares 39,000 Est. Cost $126.10 Unrealized
Revance Therapeutics Inc 0.8%
Value ($000) $4,892 Shares 236,000 Est. Cost $24.34 Unrealized
Cerner Corp 0.8%
Value ($000) $4,835 Shares 66,000 Est. Cost $61.35 Unrealized
DXCM Dexcom Inc 0.8%
Value ($000) $4,800 Shares 77,000 Est. Cost $9.43 Unrealized +60.2%
Amsurg Corp 0.8%
Value ($000) $4,676 Shares 76,000 Est. Cost $53.11 Unrealized
Tetraphase Pharmaceuticals Inc 0.8%
Value ($000) $4,470 Shares 122,000 Est. Cost $36.64 Unrealized
Intra-Cellular Therapies Inc 0.7%
Value ($000) $4,370 Shares 183,000 Est. Cost $17.63 Unrealized
Aetna Inc 0.7%
Value ($000) $4,368 Shares 41,000 Est. Cost $89.12 Unrealized
COR AmerisourceBergen Corp 0.7%
Value ($000) $4,319 Shares 38,000 Est. Cost $51.53 Unrealized +43.5%
Clovis Oncology Inc 0.7%
Value ($000) $4,008 Shares 54,000 Est. Cost $46.26 Unrealized
Abiomed Inc 0.7%
Value ($000) $3,937 Shares 55,000 Est. Cost $26.15 Unrealized
Omnicare Inc 0.6%
Value ($000) $3,853 Shares 50,000 Est. Cost $72.47 Unrealized
Keryx Biopharmaceuticals Inc 0.6%
Value ($000) $3,781 Shares 297,000 Est. Cost $12.80 Unrealized
Thoratec Corp 0.6%
Value ($000) $3,644 Shares 87,000 Est. Cost $31.71 Unrealized
Rigel Pharmaceuticals Inc 0.6%
Value ($000) $3,570 Shares 1,000,000 Est. Cost $3.57 Unrealized
CNC Centene Corp 0.6%
Value ($000) $3,393 Shares 48,000 Est. Cost $21.33 Unrealized +41.0%
HOLX Hologic Inc 0.6%
Value ($000) $3,336 Shares 101,000 Est. Cost $24.29 Unrealized +26.4%
MGNX Macrogenics Inc 0.6%
Value ($000) $3,325 Shares 106,000 Est. Cost $27.09 Unrealized +25.1%
Celldex Therapeutics Inc 0.6%
Value ($000) $3,317 Shares 119,000 Est. Cost $19.03 Unrealized
Endologix Inc 0.6%
Value ($000) $3,312 Shares 194,000 Est. Cost $14.71 Unrealized
PRGO Perrigo Co Plc 0.6%
Value ($000) $3,311 Shares 20,000 Est. Cost $159.50 Unrealized 0.0%
St Jude Medical Inc 0.5%
Value ($000) $3,192 Shares 48,800 Est. Cost $62.72 Unrealized
Ariad Pharmaceuticals Inc 0.5%
Value ($000) $3,189 Shares 387,000 Est. Cost $6.55 Unrealized
Anthera Pharmaceuticals Inc 0.5%
Value ($000) $3,135 Shares 701,314 Est. Cost $3.59 Unrealized
TEVA Teva Pharma Ind Ltd ADR repr 1 Share 0.5%
Value ($000) $3,115 Shares 50,000 Est. Cost $62.30 Unrealized
Tesaro Inc 0.5%
Value ($000) $3,042 Shares 52,999 Est. Cost $31.85 Unrealized
LGND Ligand Pharmaceuticals Inc B 0.5%
Value ($000) $3,007 Shares 39,000 Est. Cost $33.38 Unrealized +14.8%
PODD Insulet Corp 0.5%
Value ($000) $3,002 Shares 90,000 Est. Cost $35.95 Unrealized -6.1%
Cepheid Inc 0.5%
Value ($000) $2,959 Shares 52,000 Est. Cost $47.98 Unrealized
SYK Stryker Corp 0.5%
Value ($000) $2,952 Shares 32,000 Est. Cost $81.99 Unrealized 0.0%
Array BioPharma Inc 0.5%
Value ($000) $2,948 Shares 400,000 Est. Cost $4.79 Unrealized
XNCR Xencor Inc 0.5%
Value ($000) $2,911 Shares 190,000 Est. Cost $14.68 Unrealized +7.5%
Heartware Intl Inc 0.5%
Value ($000) $2,896 Shares 33,000 Est. Cost $87.76 Unrealized
OMCL Omnicell Inc 0.5%
Value ($000) $2,808 Shares 80,000 Est. Cost $32.97 Unrealized 0.0%
Achillion Pharmaceuticals Inc 0.5%
Value ($000) $2,761 Shares 280,000 Est. Cost $9.71 Unrealized
Dynavax Technologies Corp 0.5%
Value ($000) $2,755 Shares 122,835 Est. Cost $1.96 Unrealized
EW Edwards Lifesciences Corp 0.5%
Value ($000) $2,707 Shares 19,000 Est. Cost $11.54 Unrealized +94.4%
Tandem Diabetes Care Inc 0.4%
Value ($000) $2,638 Shares 209,000 Est. Cost $12.69 Unrealized
Kite Pharma Inc 0.4%
Value ($000) $2,596 Shares 45,000 Est. Cost $57.66 Unrealized
Endo International Plc 0.4%
Value ($000) $2,399 Shares 26,741 Est. Cost $89.71 Unrealized
Celladon Corp 0.4%
Value ($000) $2,274 Shares 120,053 Est. Cost $11.46 Unrealized
MYGN Myriad Genetics Inc 0.4%
Value ($000) $2,124 Shares 60,000 Est. Cost $35.53 Unrealized +0.7%
Avalanche Biotechnologies Inc 0.3%
Value ($000) $1,742 Shares 43,000 Est. Cost $40.51 Unrealized
Lexicon Pharmaceuticals Inc 0.3%
Value ($000) $1,506 Shares 1,594,805 Est. Cost $1.07 Unrealized
Mirati Therapeutics Inc 0.2%
Value ($000) $1,331 Shares 45,388 Est. Cost $29.32 Unrealized
Threshold Pharmaceuticals 0.1%
Value ($000) $818 Shares 201,537 Est. Cost $4.08 Unrealized
BIND Therapeutics Inc 0.1%
Value ($000) $733 Shares 133,535 Est. Cost $11.18 Unrealized
Chimerix Inc 0.1%
Value ($000) $535 Shares 14,200 Est. Cost $37.68 Unrealized